Published in Neurology on November 09, 2004
Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy. Mayo Clin Proc (2009) 1.29
Injuries in epilepsy: a review of its prevalence, risk factors, type of injuries and prevention. Neurol Int (2009) 0.92
Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat (2007) 0.90
Ictal spread of medial temporal lobe seizures with and without secondary generalization: an intracranial electroencephalography analysis. Epilepsia (2014) 0.86
Generalized seizure: A rare etiology of intraperitoneal rupture of the urinary bladder. Indian J Urol (2007) 0.75
Injuries in adolescents with childhood-onset epilepsy compared with sibling controls. J Pediatr (2013) 0.75
Antiepileptic drugs and suicidality. Drug Healthc Patient Saf (2010) 0.75
Injuries in Patients with Epilepsy and Some Factors Associated with Injury. Noro Psikiyatr Ars (2013) 0.75
Validity and Reliability of the Quality of Life in Epilepsy Inventory (QOLIE-31) for Turkey. Noro Psikiyatr Ars (2015) 0.75
Focal cortical seizures start as standing waves and propagate respecting homotopic connectivity. Nat Commun (2017) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Procedures for comparing samples with multiple endpoints. Biometrics (1984) 6.70
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Designs for group sequential tests. Control Clin Trials (1984) 3.56
Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc (1971) 3.35
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology (1998) 2.77
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 2.75
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology (1998) 2.70
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol (1997) 2.60
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 2.53
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol (2007) 2.46
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
1H MR spectroscopy in common dementias. Neurology (2004) 2.39
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun (1981) 2.39
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol (1996) 2.27
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology (2000) 2.26
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia (2000) 2.23
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants. Infect Immun (1981) 1.97
Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol (1991) 1.96
The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg (1976) 1.93
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology (2001) 1.92
The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics (1983) 1.89
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Effect of chemotaxis on the interaction of cholera vibrios with intestinal mucosa. Am J Clin Nutr (1979) 1.85
Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology (1991) 1.84
A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics (1999) 1.79
Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology (1995) 1.78
Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc (1993) 1.77
Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem (1992) 1.77
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI. Epilepsia (2004) 1.73
Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology (1998) 1.72
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology (1998) 1.64
Pregnancy in women with epilepsy : preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India (2001) 1.61
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology (1993) 1.57
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis (2013) 1.57
Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology (1976) 1.53
Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52
Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol (1992) 1.49
Resection of frontal encephalomalacias for intractable epilepsy: outcome and prognostic factors. Epilepsia (1997) 1.48
Theophylline effect on sleep in normal subjects. Chest (1993) 1.47
Idiopathic hypertrophic cranial pachymeningitis. Neurol India (2002) 1.46
A clinical approach to the classification of seizures and epileptic syndromes. Mayo Clin Proc (1996) 1.45
Measurements of glucose control. Diabetes Care (1987) 1.45
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J (1980) 1.44
Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. Mayo Clin Proc (1989) 1.43
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43
The therapeutic impact of temporal artery biopsy. Lancet (1983) 1.42
Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol (1999) 1.42
Introduction of automated systems to evaluate touch-pressure, vibration, and thermal cutaneous sensation in man. Ann Neurol (1978) 1.42
Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc (1990) 1.42
Prevalence of monoclonal protein in peripheral neuropathy. Neurology (1981) 1.41
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2005) 1.41
Acute postoperative seizures following anterior temporal lobectomy for intractable partial epilepsy. J Neurosurg (1998) 1.40
Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin Proc (1997) 1.40
Psychogenic nonepileptic seizures. Mayo Clin Proc (1996) 1.40
Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study. Neurology (1998) 1.39
Late survival after abdominal aortic aneurysm repair: influence of coronary artery disease. J Vasc Surg (1984) 1.38
Nimodipine as an add-on therapy for intractable epilepsy. Mayo Clin Proc (1995) 1.38
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology (1992) 1.38
The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia (2001) 1.37
Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence? Health Serv Res (1994) 1.37
Risk factors for nursing home placement in a population-based dementia cohort. J Am Geriatr Soc (2000) 1.37